The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Adminis

vaccine - Trending on BuzzSumo 2023-05-18

Summary:

The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Adminis prnewswire.com

Link:

https://www.prnewswire.com/news-releases/the-first-of-its-kind-in-the-world-the-recombinant-multivalent-covid-19-protein-vaccine-against-xbb-variants-by-westvac-biopharmawest-china-medical-center-sichuan-university-has-been-approved-for-clinical-trials-by-the-national-301828543.html

From feeds:

Tags:

all_vaccine

Authors:

Westvac Biopharma Co.

Date tagged:

05/18/2023, 10:05

Date published:

05/18/2023, 09:15